Search research articles
Contact Us
Filters
Showing results (71-80 of 179) with videos related to
Page
of 18
Sort By:
International Journal of Molecular Sciences
|
November 14, 2023
Long-Term Tumor Control Following Targeted Alpha Therapy (TAT) of Low-Grade Gliomas (LGGs): A New Treatment Paradigm?
Leszek Krolicki, Jolanta Kunikowska, Dominik Cordier, et al.
Chemical Biology & Drug Design
|
April 4, 2018
In vitro evaluation of <sup>225</sup> Ac-DOTA-substance P for targeted alpha therapy of glioblastoma multiforme
Agnieszka Majkowska-Pilip, Maria Rius, Frank Bruchertseifer, et al.
Cancer Biology & Therapy
|
July 16, 2015
Fractionated intravesical radioimmunotherapy with (213)Bi-anti-EGFR-MAb is effective without toxic side-effects in a nude mouse model of advanced human bladder carcinoma
Julia Fazel, Silvia Rötzer, Christof Seidl, et al.
Dalton Transactions (Cambridge, England : 2003)
|
September 18, 2013
Structure and spectroscopy of hydrated neptunyl(VI) nitrate complexes
Patric Lindqvist-Reis, Christos Apostolidis, Olaf Walter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 15, 2017
Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with <sup>225</sup>Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding
Clemens Kratochwil, Frank Bruchertseifer, Hendrik Rathke, et al.
Molecular Cancer Therapeutics
|
August 19, 2007
213Bi-induced death of HSC45-M2 gastric cancer cells is characterized by G2 arrest and up-regulation of genes known to prevent apoptosis but induce necrosis and mitotic catastrophe
Christof Seidl, Matthias Port, Klaus-Peter Gilbertz, et al.
Nuclear Medicine and Biology
|
November 12, 2013
²¹³Bi-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cells
Anja Pickhard, Guido Piontek, Christof Seidl, et al.
EJNMMI Research
|
July 20, 2017
Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model
Jessie R Nedrow, Anders Josefsson, Sunju Park, et al.
Analytical Chemistry
|
October 18, 2008
Production of 230U/226Th for targeted alpha therapy via proton irradiation of 231Pa
Alfred Morgenstern, Ondrej Lebeda, Jan Stursa, et al.
Plos One
|
March 17, 2016
Long-Term Toxicity of 213Bi-Labelled BSA in Mice
Laëtitia Dorso, Edith Bigot-Corbel, Jérôme Abadie, et al.
Page
of 18
Search research articles
Search
Showing results (71-80 of 179) with videos related to
Sort By:
Page
of 18
International Journal of Molecular Sciences
|
November 14, 2023
Long-Term Tumor Control Following Targeted Alpha Therapy (TAT) of Low-Grade Gliomas (LGGs): A New Treatment Paradigm?
Leszek Krolicki, Jolanta Kunikowska, Dominik Cordier, et al.
Chemical Biology & Drug Design
|
April 4, 2018
In vitro evaluation of <sup>225</sup> Ac-DOTA-substance P for targeted alpha therapy of glioblastoma multiforme
Agnieszka Majkowska-Pilip, Maria Rius, Frank Bruchertseifer, et al.
Cancer Biology & Therapy
|
July 16, 2015
Fractionated intravesical radioimmunotherapy with (213)Bi-anti-EGFR-MAb is effective without toxic side-effects in a nude mouse model of advanced human bladder carcinoma
Julia Fazel, Silvia Rötzer, Christof Seidl, et al.
Dalton Transactions (Cambridge, England : 2003)
|
September 18, 2013
Structure and spectroscopy of hydrated neptunyl(VI) nitrate complexes
Patric Lindqvist-Reis, Christos Apostolidis, Olaf Walter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 15, 2017
Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with <sup>225</sup>Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding
Clemens Kratochwil, Frank Bruchertseifer, Hendrik Rathke, et al.
Molecular Cancer Therapeutics
|
August 19, 2007
213Bi-induced death of HSC45-M2 gastric cancer cells is characterized by G2 arrest and up-regulation of genes known to prevent apoptosis but induce necrosis and mitotic catastrophe
Christof Seidl, Matthias Port, Klaus-Peter Gilbertz, et al.
Nuclear Medicine and Biology
|
November 12, 2013
²¹³Bi-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cells
Anja Pickhard, Guido Piontek, Christof Seidl, et al.
EJNMMI Research
|
July 20, 2017
Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model
Jessie R Nedrow, Anders Josefsson, Sunju Park, et al.
Analytical Chemistry
|
October 18, 2008
Production of 230U/226Th for targeted alpha therapy via proton irradiation of 231Pa
Alfred Morgenstern, Ondrej Lebeda, Jan Stursa, et al.
Plos One
|
March 17, 2016
Long-Term Toxicity of 213Bi-Labelled BSA in Mice
Laëtitia Dorso, Edith Bigot-Corbel, Jérôme Abadie, et al.
Page
of 18